Extended anticoagulation for prevention of recurrent venous thromboembolism in carriers of factor V Leiden - Cost-effectiveness analysis (vol 84, pg 752, 2000)

被引：0
|
作者：
Marchetti, M
Pistorio, A
Barosi, G
机构：
来源：
THROMBOSIS AND HAEMOSTASIS | 2000年 / 84卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1112 / 1112
页数：1
相关论文
共 50 条
  • [1] Extended anticoagulation for prevention of recurrent venous thromboembolism in carriers of factor V Leiden - Cost-effectiveness analysis
    Marchetti, M
    Pistorio, A
    Barosi, G
    THROMBOSIS AND HAEMOSTASIS, 2000, 84 (05) : 752 - 757
  • [2] Cost-Effectiveness Analysis of Extended Duration Anticoagulation with Rivaroxaban to Prevent Recurrent Venous Thromboembolism
    Coleman, Craig I.
    Limone, Brendan L.
    Bookhart, Brahim K.
    Mody, Samir H.
    Nutescu, Edith A.
    THROMBOSIS RESEARCH, 2014, 133 (05) : 743 - 749
  • [3] Testing for factor V Leiden in patients with pulmonary or venous thromboembolism: A cost-effectiveness analysis
    Eckman, MH
    Singh, SK
    Erban, JK
    Kao, G
    MEDICAL DECISION MAKING, 2002, 22 (02) : 108 - 124
  • [4] Cost-effectiveness of screening and extended anticoagulation for carriers of both factor V Leiden and prothrombin G20210A
    Marchetti, M
    Quaglini, S
    Barosi, G
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 2001, 94 (07): : 365 - 372
  • [5] The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism
    Eichinger, S
    Weltermann, A
    Mannhalter, C
    Minar, E
    Bialonczyk, C
    Hirschl, M
    Schönauer, V
    Lechner, K
    Kyrle, PA
    ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (20) : 2357 - 2360
  • [6] Cost-effectiveness of rivaroxaban versus warfarin anticoagulation for the prevention of recurrent venous thromboembolism: A US perspective
    Seaman, Craig D.
    Smith, Kenneth J.
    Ragni, Margaret V.
    THROMBOSIS RESEARCH, 2013, 132 (06) : 647 - 651
  • [7] The risk for recurrent venous thromboembolism in carriers of factor V Leiden and prothrombin mutation
    Tormene, D.
    Carraro, S.
    Ferri, V
    Simioni, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 875 - 875
  • [8] Duration of anticoagulation and risk of recurrent thromboembolism in carriers of factor V Leiden or prothrombin mutation
    Prandoni, P.
    Tormene, D.
    Spiezia, L.
    Pesavento, R.
    Simioni, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (12)
  • [9] Influence of concomitant thrombophilic defects on the risk of recurrent venous thromboembolism in carriers of factor V Leiden
    Meinardi, JR
    Middeldorp, S
    Katerberg, H
    de Kam, PJ
    Koopman, MMW
    van Pampus, ECM
    Hamulyák, K
    Prins, MH
    Büller, HR
    van der Meer, J
    THROMBOSIS AND HAEMOSTASIS, 1999, : 419 - 419
  • [10] The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders
    Meinardi, JR
    Middeldorp, S
    de Kam, PJ
    Koopman, MMW
    van Pampus, ECM
    Hamulyák, K
    Prins, MH
    Büller, HR
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (03) : 625 - 631
12345